CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in VYGR — Voyager Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in VYGR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$482,936
-$58,963 QoQ
Shares Held
125,113
-9.3% QoQ
Ownership
0.207%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. VYGR ranks #225 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in VYGR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $482,936 | 125,113 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $541,899 | 137,888 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $643,955 | 137,892 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $382,685 | 123,050 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $464,989 | 137,571 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $780,027 | 137,571 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $804,240 | 137,477 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,059,971 | 134,004 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,065,548 | 114,452 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $715,180 | 84,737 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $683,340 | 88,173 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $973,879 | 85,055 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $95,958 | 12,446 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $75,920 | 12,446 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $73,680 | 12,446 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $73,555 | 12,446 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $121,234 | 15,910 | Shares | Sole | 2022-05-13 | |
| 2021-06-30 | $471,877 | 114,256 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $776,580 | 164,879 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,214,713 | 169,890 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,784,312 | 167,227 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,103,476 | 166,678 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $1,885,833 | 206,102 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||